KOD
Price
$5.52
Change
+$0.33 (+6.36%)
Updated
Jul 18 closing price
Capitalization
291.25M
30 days until earnings call
LXEO
Price
$4.15
Change
-$0.11 (-2.58%)
Updated
Jul 18 closing price
Capitalization
224.03M
30 days until earnings call
Interact to see
Advertisement

KOD vs LXEO

Header iconKOD vs LXEO Comparison
Open Charts KOD vs LXEOBanner chart's image
Kodiak Sciences
Price$5.52
Change+$0.33 (+6.36%)
Volume$513.36K
Capitalization291.25M
Lexeo Therapeutics
Price$4.15
Change-$0.11 (-2.58%)
Volume$227.92K
Capitalization224.03M
KOD vs LXEO Comparison Chart in %
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. LXEO commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and LXEO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (KOD: $5.19 vs. LXEO: $4.26)
Brand notoriety: KOD and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 138% vs. LXEO: 66%
Market capitalization -- KOD: $291.25M vs. LXEO: $224.03M
KOD [@Biotechnology] is valued at $291.25M. LXEO’s [@Biotechnology] market capitalization is $224.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 5 TA indicator(s) are bullish while LXEO’s TA Score has 3 bullish TA indicator(s).

  • KOD’s TA Score: 5 bullish, 4 bearish.
  • LXEO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, KOD is a better buy in the short-term than LXEO.

Price Growth

KOD (@Biotechnology) experienced а +15.59% price change this week, while LXEO (@Biotechnology) price change was -7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2025.

LXEO is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($291M) has a higher market cap than LXEO($224M). LXEO YTD gains are higher at: -35.258 vs. KOD (-47.839). LXEO has higher annual earnings (EBITDA): -107.14M vs. KOD (-162.44M). KOD has more cash in the bank: 139M vs. LXEO (99.8M). LXEO has less debt than KOD: LXEO (9.4M) vs KOD (67.6M). KOD (0) and LXEO (0) have equivalent revenues.
KODLXEOKOD / LXEO
Capitalization291M224M130%
EBITDA-162.44M-107.14M152%
Gain YTD-47.839-35.258136%
P/E RatioN/AN/A-
Revenue00-
Total Cash139M99.8M139%
Total Debt67.6M9.4M719%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KODLXEO
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UOVEF29.851.31
+4.59%
United Overseas Bank Ltd.
IBIDF43.00N/A
N/A
Ibiden Co. Ltd.
MGLLF6.42N/A
N/A
Magellan Financial Group Ltd.
FKMCF0.11N/A
N/A
FOKUS MNG CORP.
INNMF0.21-0.01
-4.77%
Amplia Therapeutics Ltd.

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+9.61%
XNCR - KOD
55%
Loosely correlated
+2.72%
BEAM - KOD
49%
Loosely correlated
+1.89%
IDYA - KOD
48%
Loosely correlated
-0.27%
NRIX - KOD
48%
Loosely correlated
-2.66%
IMNM - KOD
45%
Loosely correlated
+8.07%
More